Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Sunday, September 27

1:30 PM - 1:40 PM ET

6 - Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis<em></em>
Speaker: Tran, Phuoc, MD, PhD - University of Texas MD Anderson Cancer Center, Houston, Texas
1:30 PM - 1:40 PM ET

Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis<em></em>
Speaker: Tran, Phuoc, MD, PhD - University of Texas MD Anderson Cancer Center, Houston, Texas
1:40 PM - 1:50 PM ET

7 - Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003
Speaker: Buyyounouski, Mark, MD, MS, FASTRO - Stanford University, Stanford, CA
1:40 PM - 1:50 PM ET

Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003
Speaker: Buyyounouski, Mark, MD, MS, FASTRO - Stanford University, Stanford, CA
2:00 PM - 2:10 PM ET

9 - 6-Year Overall Survival of Nivolumab Following Stereotactic Ablative Radiotherapy In Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
Speaker: Chang, Joe, MD, PhD, MS, FASTRO - MD Anderson Cancer Center, Houston, TX
2:10 PM - 2:20 PM ET

10 - Phase II Multi-Institutional Study of Ultralow-Dose (4Gy) Response-Adapted Radiotherapy for Symptomatic Bone Metastases from Multiple Myeloma
Speaker: Ballas, Leslie, MD, FASTRO - Cedars Sinai, Los Angeles, CA
2:20 PM - 2:30 PM ET

11 - Stereotactic Body Radiation Therapy (SBRT) and Comprehensive Metastasis-Directed Therapy for Ewing Sarcoma Patients Enrolled on AEWS1221: A Report from the Children's Oncology Group (COG)
Speaker: Laack, Nadia, MD, MS - Mayo Clinic, Rochester, MN
3:00 PM - 3:10 PM ET

100 - Multimodal Modeling of Detailed Cancer Subtypes and Molecular Features from >60,000 Patients with Co-Registered H&E Images and Clinical Tumor Sequencing
Speaker: Boehm, Kevin, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:00 PM - 3:10 PM ET

105 - Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial
Speaker: Lapierre, Ariane, MD, PhD - Hopital Lyon Sud, Pierre Benite
3:00 PM - 3:10 PM ET

110 - Pooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer Demonstrating Reduced Toxicity with Durable Long-Term Control
Speaker: Lee, Nancy, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York, NY
3:00 PM - 3:10 PM ET

115 - International Pilot of an Immersive Virtual-Reality-Based Training in Intracavitary Cervical Cancer Brachytherapy Treatment: Educational Impact and Early Outcomes
Speaker: Peterson, John, MD - H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3:00 PM - 3:10 PM ET

121 - Pirfenidone for Cancer Patients with Grade 2 and Grade 3 Radiation-Induced Lung Injury: Long-Term Efficacy and Exploratory Analysis from a Multicenter, Randomized Phase ll Clinical Trial
Speaker: Chen, Biqi, MD - Sun Yat-sen University Cancer Center, Guangzhou, Guangdong